Confirming Your Diagnosis: Labs and Pathology for Hb Lepore
At a Glance
Hb Lepore is confirmed by combining a complete blood count, iron studies, hemoglobin fractionation, and specialized genetic testing. Because HPLC can confuse Hb Lepore with HbA2 and routine sequencing may miss the gene fusion, the testing method matters.
Diagnosing Hemoglobin Lepore (Hb Lepore) is often a multi-step process. Because it mimics the appearance of beta-thalassemia or iron deficiency under a microscope, standard screening tests can sometimes lead to an incomplete diagnosis. A definitive diagnosis requires looking at both the physical structure of your hemoglobin and the genetic “blueprints” that created it [1][2].
Step 1: The Initial Clues (CBC and Smear)
The first sign of Hb Lepore usually appears on a routine Complete Blood Count (CBC). People with the Hb Lepore trait (carriers) or the syndrome often show microcytosis (unusually small red blood cells) and hypochromia (cells that are paler than normal because they lack enough hemoglobin) [1][3]. These findings are identical to those seen in iron deficiency or standard beta-thalassemia, which is why your doctor will likely order iron studies to rule out simple iron deficiency before moving to more specific testing.
Step 2: Measuring Hemoglobin Types
Doctors use techniques called High-Performance Liquid Chromatography (HPLC) or Capillary Electrophoresis (CE) to separate and measure the different types of hemoglobin in your blood.
On these reports, your hemoglobin is broken down into percentages. Hb Lepore typically creates a unique “peak” or “window,” but its exact appearance depends heavily on the specific machine the laboratory uses [4].
- In Carriers (Trait): You will typically see an Hb Lepore fraction around 5% to 15% [1]. You may also see mildly increased HbF (fetal hemoglobin) and a decrease in HbA (the main adult hemoglobin) [5]. Note that a recent blood transfusion can temporarily alter these percentages.
- In the Disease (Homozygous): You will generally see no HbA at all. Instead, the blood is dominated by HbF and a fraction of Hb Lepore [6][7].
- The Diagnostic Trap: In some HPLC systems, Hb Lepore “co-elutes” with HbA2—meaning the machine cannot tell them apart and spits them out at the exact same time [4]. This can lead to a falsely elevated HbA2 reading, which might cause a clinician to misdiagnose you with standard beta-thalassemia trait instead of identifying the Hb Lepore variant [5].
Step 3: Genetic Molecular Testing
Most standard genetic tests for thalassemia use Sanger sequencing, which “reads” the letters of the beta-globin gene one by one. Because Hb Lepore is caused by a fusion of two different genes (delta and beta) rather than a simple spelling error within one gene, a routine sequencing test might come back “normal” [2][8]. A normal Sanger sequence does not prove you don’t have Hb Lepore; it simply means the wrong assay was used.
To find Hb Lepore, labs must use specialized tools designed to detect large structural changes:
- Gap-PCR: This method is highly effective for identifying known, common fusion breakpoints. It uses chemical markers to bridge the “gap” created by the delta-beta fusion [2][9].
- MLPA: This technique helps count the number of gene copies to see if parts of the gene cluster are missing or rearranged, though it may not define the exact junction [10].
- Long-Read Sequencing: If Gap-PCR misses an atypical rearrangement, newer technologies that read very long stretches of DNA can be used to identify the exact “breakpoint” where the fusion occurred [10][11].
Parental Testing: The Family Map
Because Hb Lepore is inherited, testing your parents is a useful way to support a complex diagnosis [12]. If one parent has the Hb Lepore trait and the other has a standard beta-thalassemia trait, it helps explain why a child might have a more severe “compound heterozygous” condition [12][13]. While parental testing doesn’t replace your own genetic confirmation, it provides vital context.
Useful Information to Seek on Your Report
A comprehensive pathology work-up for Hb Lepore will contain several key pieces of information. While not every lab will report all of these in a single document, these are the elements you and your hematologist should discuss:
- Hemoglobin Fractionation: Specific percentages for HbA, HbA2, HbF, and the variant fraction [1].
- Platform Disclosure: A note stating whether HPLC or Capillary Electrophoresis was used, as this affects how the co-elution of HbA2 is interpreted [4].
- Molecular Confirmation: Results from a specialized test like Gap-PCR, MLPA, or long-read sequencing identifying the fusion [2].
- Iron Studies & Transfusion History: Confirmation of whether you had a recent transfusion (which alters results) and whether your iron levels are normal.
- Genotype Conclusion: A statement defining whether you are a carrier (heterozygous) or have the syndrome (homozygous/compound heterozygous) [14].
Common questions in this guide
What tests confirm Hb Lepore?
Can Hb Lepore be mistaken for iron deficiency or beta-thalassemia?
What does Hb Lepore usually look like on a hemoglobin test?
Why might a routine genetic test miss Hb Lepore?
Why does the laboratory method matter for Hb Lepore results?
Can testing my parents help confirm Hb Lepore?
What information should I look for in an Hb Lepore laboratory report?
Get notified when new evidence is published on Hemoglobin Lepore-beta-thalassemia syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (14)
- 1
Rare occurrence of hemoglobin Lepore variant in a Palestinian patient: a case report and brief literature review.
Asees MY, Shrateh ON, Jobran AWM, Assi AS
Annals of medicine and surgery (2012) 2023; (85(10)):5219-5222 doi:10.1097/MS9.0000000000001212.
PMID: 37811104 - 2
Molecular characterization of similar Hb Lepore Boston-Washington in four Chinese families using third generation sequencing.
Zhuang J, Zhang N, Zheng Y, et al.
Scientific reports 2024; (14(1)):9966 doi:10.1038/s41598-024-60604-7.
PMID: 38693200 - 3
Hb lepore/β0-thalassaemia with α+-thalassaemia interactions, a potential diagnostic pitfall.
Alauddin H, Mohamad Nasir S, Ahadon M, et al.
The Malaysian journal of pathology 2015; (37(3)):287-92.
PMID: 26712677 - 4
Comparison of Two High-Pressure Liquid Chromatography Instruments Bio-Rad Variant-II and Tosoh HLC-723G11 in the Evaluation of Hemoglobinopathies.
Chopra P, Bhardwaj S, Negi P, Arora A
Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion 2020; (36(4)):725-732 doi:10.1007/s12288-020-01298-5.
PMID: 33100717 - 5
Genetic and non-genetic factors affecting hemoglobin A2 expression in a large cohort of Thai individuals: implication for population screening for thalassemia.
Singha K, Sanchaisuriya K, Fucharoen G, Fucharoen S
American journal of translational research 2021; (13(10)):11632-11642.
PMID: 34786089 - 6
Homozygous Hemoglobin Lepore: A Rare Condition Seen in a Bangladeshi Family.
Aziz MA, Khan WA, Das SA, Banu B
Mymensingh medical journal : MMJ 2021; (30(4)):1172-1176.
PMID: 34605493 - 7
Corpuscular Haemolytic Anaemias - Lepore Haemoglobinopathy.
Tudorascu I, Neamtu S, Stanca L, et al.
Current health sciences journal 2014; (40(4)):281-4 doi:10.12865/CHSJ.40.04.10.
PMID: 26793325 - 8
Identification of rare thalassemia variants using third-generation sequencing.
Liu Q, Chen Q, Zhang Z, et al.
Frontiers in genetics 2022; (13()):1076035 doi:10.3389/fgene.2022.1076035.
PMID: 36685902 - 9
Screening for common β-globin gene cluster deletions in Chinese individuals with increased hemoglobin F.
Cai WJ, Li J, Xie XM, Li DZ
International journal of laboratory hematology 2015; (37(6)):752-7 doi:10.1111/ijlh.12401.
PMID: 26179971 - 10
Identification of Hb Lepore, Hb anti-Lepore, and α-globin gene triplications by long-read single-molecule real-time sequencing.
Xu A, Ye Y, Huang Y, et al.
American journal of clinical pathology 2024; (161(4)):411-417 doi:10.1093/ajcp/aqad155.
PMID: 38037185 - 11
Biochemical and Molecular Analysis of the Hb Lepore Boston Washington in a Syrian Homozygous Child.
Pirastru M, Manca L, Trova S, Mereu P
BioMed research international 2017; (2017()):1261972 doi:10.1155/2017/1261972.
PMID: 28553644 - 12
β-Thalassemia Intermedia Caused by Compound Heterozygosity for Hb Lepore-Hollandia and β-Thalassemia is Rare in the Indian Population.
Sreedharanunni S, Chhabra S, Hira JK, et al.
Hemoglobin 2015; (39(5)):362-5 doi:10.3109/03630269.2015.1064004.
PMID: 26291970 - 13
[Clinical Diagnosis and Prenatal Screening of Hb Lepore-BW Associated with IVS-II-654 Heterozygous Mutation].
Bai HL, Cheng W, Cui J, et al.
Zhongguo shi yan xue ye xue za zhi 2022; (30(2)):529-533 doi:10.19746/j.cnki.issn.1009-2137.2022.02.034.
PMID: 35395991 - 14
Molecular and clinical analysis of haemoglobin Lepore in Campania, a region of Southern Italy.
Ricchi P, Ammirabile M, Spasiano A, et al.
Hematology (Amsterdam, Netherlands) 2017; (22(7)):437-443 doi:10.1080/10245332.2017.1289304.
PMID: 28218017
This page is for informational purposes only and does not constitute medical advice about Hb Lepore. A hematologist or qualified clinician should interpret your laboratory and genetic results and advise you about next steps.